Thürmer H, Lund-Larsen P G, Tverdal A
Statens helseundersøkelser, Oslo.
Tidsskr Nor Laegeforen. 1994 Oct 10;114(24):2835-9.
Baseline (1974-76) and repeat (1977-81) cardiovascular screenings of 21,314 men aged 35-49 years brought to light 840 men who had started treatment between screenings. These were compared with men who had remained untreated. The effects of treatment on blood pressure were small, and normal target blood pressures rare. At pretreatment blood pressure up to systolic 184 mm Hg, and in most risk strata, both total mortality and cardiovascular mortality were higher among the men on treatment. This study shows an adverse effect of treatment in a population setting, particularly at low pretreatment blood pressure, and if blood pressure increases upon treatment.
对21314名年龄在35至49岁之间的男性进行了基线(1974 - 1976年)和重复(1977 - 1981年)心血管筛查,发现有840名男性在两次筛查期间开始接受治疗。将这些男性与未接受治疗的男性进行了比较。治疗对血压的影响很小,达到正常血压目标的情况很少见。在治疗前收缩压高达184毫米汞柱时,以及在大多数风险分层中,接受治疗的男性的总死亡率和心血管死亡率都更高。这项研究表明,在人群中治疗存在不良影响,尤其是在治疗前血压较低以及治疗后血压升高的情况下。